Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BMY
GSK
Add up to 3 more stocks
BMY
Bristol-Myers Squibb Company
-0.50%
$61.15-0.31Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$124.91B
52W Range
$42.52 - $68.64
GSK
GSK plc
-0.32%
$47.03-0.15Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$94.22B
52W Range
$42.85 - $61.70
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 13.47 | 14.87 |
| Forward P/E | 8.79 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 5.60 | 4.05 |
| P/S Ratio | 2.54 | 2.13 |
| P/FCF Ratio | 10.92 | 10.10 |
| EV/EBITDA | 9.41 | 7.68 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 70.2% | 72.7% |
| Operating Margin | 28.3% | 20.7% |
| Net Margin | 18.9% | 14.5% |
| ROE | 41.6% | 27.7% |
| ROA | 10.6% | 7.9% |
| ROIC | 15.5% | 13.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.53 | 0.82 |
| Quick Ratio | 1.38 | 0.52 |
| Debt/Equity | 1.93 | 1.03 |
| Interest Coverage | 7.26 | 12.14 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 4.1% | 3.9% |
| Payout Ratio | 55.5% | 57.5% |
| Yrs of Dividend Growth | 16 | 2 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.